Palatin director granted 2,400 stock options

Palatin Technologies director Arlene Morris received a grant of stock options covering 2,400 shares of common stock with an exercise price of $7.70 per share.

Rhea-AI Filing Summary

Palatin Technologies director Arlene Morris received a grant of stock options covering 2,400 shares of common stock with an exercise price of $7.70 per share. The options vest 50% on August 3, 2027 and 50% on August 3, 2028, and expire on August 3, 2037. After this award, she directly holds 3,497 stock options. The grant was approved by the Compensation Committee under Palatin’s 2011 Stock Incentive Plan and is reported under a Rule 10b5-1 trading arrangement.

Insider Trade Summary 10b5-1

Voting Trust: 2,400 shares

Voting Trust 1 txn

Insider Morris Arlene

Role Director

Type	Security	Shares	Price	Value
Voting Trust	Stock Option (Right to Buy) F1	2,400	$0.00	$0.00

Holdings After Transaction: Stock Option (Right to Buy) — 3,497 contracts (Direct)

Footnotes (1)

1. F1. Stock Option granted under the 2011 Stock Incentive Plan as amended. The option vests as to 50% on August 3, 2027 and as to the remaining 50% on August 3, 2028. The option was granted by the Compensation Committee on August 3, 2026, and there was no impediment to the grant of option.

Key Figures

Stock options granted: 2,400 shares Exercise price: $7.70 per share Options expiration: August 3, 2037 +3 more

6 metrics

Stock options granted 2,400 shares Stock Option (Right to Buy) granted to director Arlene Morris

Exercise price $7.70 per share Conversion or exercise price of the granted stock option

Options expiration August 3, 2037 Expiration date of the granted stock option

Options after transaction 3,497 options Total derivative securities held directly after the grant

First vesting date August 3, 2027 50% of the option grant vests on this date

Second vesting date August 3, 2028 Remaining 50% of the option grant vests on this date

Key Terms

Stock Option (Right to Buy), 2011 Stock Incentive Plan, Compensation Committee, voting trust

4 terms

Stock Option (Right to Buy) financial

"Security titled "Stock Option (Right to Buy)" reported as derivative"

2011 Stock Incentive Plan financial

"Stock Option granted under the 2011 Stock Incentive Plan as amended"

Compensation Committee financial

"The option was granted by the Compensation Committee on August 3, 2026"

A compensation committee is a group within a company's leadership responsible for setting and reviewing how much top executives and employees are paid, including salaries, bonuses, and benefits. It matters to investors because fair and effective pay decisions can influence a company's performance, leadership motivation, and overall governance, helping ensure that the company’s management is aligned with shareholders’ interests.

voting trust regulatory

"Transaction code Z described as deposit into or withdrawal from voting trust"

A voting trust is an arrangement where shareholders temporarily transfer their voting rights to one or more trusted individuals (trustees) who vote on company matters on their behalf. It matters to investors because it consolidates decision-making power—like handing the car keys to a single driver for a journey—which can stabilize leadership or push through strategic plans but also reduces individual shareholders’ direct influence and can affect the company’s direction and stock value.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Palatin Technologies (PTN) report for director Arlene Morris?

Palatin Technologies reported that director Arlene Morris received a grant of 2,400 stock options to buy common shares. These options carry a $7.70 exercise price, vest in two equal installments in 2027 and 2028, and expire in 2037 under the 2011 Stock Incentive Plan.

What are the vesting terms of Arlene Morris’s new Palatin (PTN) stock options?

The 2,400 stock options granted to Arlene Morris vest as to 50% on August 3, 2027 and the remaining 50% on August 3, 2028. This two-year vesting schedule is specified in the grant under Palatin’s 2011 Stock Incentive Plan.

What is the exercise price and expiration date of the new PTN options granted to Arlene Morris?

The options granted to Arlene Morris have an exercise price of $7.70 per share and expire on August 3, 2037. This means she may exercise the right to buy Palatin common stock at $7.70 until that expiration date, subject to vesting.

How many Palatin Technologies (PTN) stock options does Arlene Morris hold after this Form 4 transaction?

Following this reported grant, Arlene Morris directly holds 3,497 stock options in Palatin Technologies. This figure reflects her total derivative securities of this type after receiving the new 2,400-option award disclosed in the Form 4.

Under what plan and approval was the PTN option grant to Arlene Morris made?

The stock option grant to Arlene Morris was made under Palatin’s 2011 Stock Incentive Plan, as amended, and was approved by the company’s Compensation Committee. The Form 4 notes the grant date as August 3, 2026, with specified vesting and expiration terms.

Was the Palatin (PTN) director option grant reported in connection with a Rule 10b5-1 trading arrangement?

Yes. The Form 4 for Palatin Technologies indicates the transaction is affirmed under a Rule 10b5-1 trading arrangement. This checkbox signals that the reported grant was made pursuant to a pre-established plan meeting Rule 10b5-1 conditions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/05/2026 - 04:31 PM Accepted by SEC EDGAR 08/05/2026 - 04:30 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Morris Arlene

(Last) (First) (Middle)

PALATIN TECHNOLOGIES, INC.

301 CARNEGIE CENTER DRIVE, SUITE 304

(Street)

PRINCETON, NEW JERSEY 08540

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
PALATIN TECHNOLOGIES INC [ PTN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/03/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$7.7	08/03/2026		Z		2,400		08/03/2027(1)	08/03/2037	Common Stock	2,400	$0	3,497	D

Explanation of Responses:

1. Stock Option granted under the 2011 Stock Incentive Plan as amended. The option vests as to 50% on August 3, 2027 and as to the remaining 50% on August 3, 2028. The option was granted by the Compensation Committee on August 3, 2026, and there was no impediment to the grant of option.

	/s/ Arlene Morris, by Stephen A. Slusher, Attorney-in-Fact	08/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)